キッセイ薬品工業の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2022/05/02 | 2,562 | 2,596 | 2,545 | 2,591 | +20 | +0.8% | 76,500 |
2022/04/28 | 2,452 | 2,571 | 2,452 | 2,571 | +128 | +5.2% | 79,200 |
2022/04/27 | 2,494 | 2,529 | 2,423 | 2,443 | -87 | -3.4% | 293,800 |
2022/04/26 | 2,555 | 2,572 | 2,514 | 2,530 | -2 | -0.1% | 90,300 |
2022/04/25 | 2,504 | 2,544 | 2,492 | 2,532 | +28 | +1.1% | 98,900 |
2022/04/22 | 2,446 | 2,504 | 2,445 | 2,504 | +38 | +1.5% | 73,500 |
2022/04/21 | 2,446 | 2,470 | 2,444 | 2,466 | +31 | +1.3% | 91,100 |
2022/04/20 | 2,414 | 2,441 | 2,399 | 2,435 | +35 | +1.5% | 70,100 |
2022/04/19 | 2,400 | 2,426 | 2,395 | 2,400 | -28 | -1.2% | 72,500 |
2022/04/18 | 2,438 | 2,463 | 2,400 | 2,428 | -48 | -1.9% | 53,000 |
2022/04/15 | 2,470 | 2,483 | 2,454 | 2,476 | +4 | +0.2% | 57,700 |
2022/04/14 | 2,455 | 2,476 | 2,446 | 2,472 | +8 | +0.3% | 55,400 |
2022/04/13 | 2,411 | 2,467 | 2,411 | 2,464 | +29 | +1.2% | 67,800 |
2022/04/12 | 2,482 | 2,501 | 2,435 | 2,435 | -70 | -2.8% | 62,200 |
2022/04/11 | 2,485 | 2,505 | 2,468 | 2,505 | +20 | +0.8% | 87,200 |
2022/04/08 | 2,479 | 2,487 | 2,438 | 2,485 | +56 | +2.3% | 151,000 |
2022/04/07 | 2,405 | 2,430 | 2,389 | 2,429 | +6 | +0.2% | 72,100 |
2022/04/06 | 2,445 | 2,486 | 2,417 | 2,423 | -48 | -1.9% | 72,600 |
2022/04/05 | 2,486 | 2,528 | 2,457 | 2,471 | -42 | -1.7% | 104,700 |
2022/04/04 | 2,555 | 2,555 | 2,501 | 2,513 | -31 | -1.2% | 64,500 |
2022/04/01 | 2,543 | 2,560 | 2,517 | 2,544 | -11 | -0.4% | 117,200 |
2022/03/31 | 2,571 | 2,612 | 2,545 | 2,555 | -52 | -2% | 108,100 |
2022/03/30 | 2,570 | 2,614 | 2,567 | 2,607 | -27 | -1% | 134,400 |
2022/03/29 | 2,657 | 2,658 | 2,601 | 2,634 | +34 | +1.3% | 114,300 |
2022/03/28 | 2,602 | 2,614 | 2,589 | 2,600 | +6 | +0.2% | 60,800 |
2022/03/25 | 2,584 | 2,611 | 2,584 | 2,594 | +42 | +1.6% | 100,200 |
2022/03/24 | 2,563 | 2,563 | 2,506 | 2,552 | -36 | -1.4% | 91,600 |
2022/03/23 | 2,556 | 2,595 | 2,519 | 2,588 | +60 | +2.4% | 99,700 |
2022/03/22 | 2,547 | 2,554 | 2,518 | 2,528 | +12 | +0.5% | 112,800 |
2022/03/18 | 2,511 | 2,519 | 2,476 | 2,516 | +13 | +0.5% | 270,600 |
2022/03/17 | 2,529 | 2,530 | 2,493 | 2,503 | -2 | -0.1% | 141,600 |
2022/03/16 | 2,480 | 2,523 | 2,478 | 2,505 | +45 | +1.8% | 127,300 |
2022/03/15 | 2,452 | 2,475 | 2,441 | 2,460 | +3 | +0.1% | 96,800 |
2022/03/14 | 2,451 | 2,468 | 2,415 | 2,457 | +12 | +0.5% | 105,200 |
2022/03/11 | 2,440 | 2,461 | 2,430 | 2,445 | -15 | -0.6% | 99,300 |
2022/03/10 | 2,411 | 2,460 | 2,391 | 2,460 | +91 | +3.8% | 123,700 |
2022/03/09 | 2,392 | 2,392 | 2,349 | 2,369 | -36 | -1.5% | 145,600 |
2022/03/08 | 2,400 | 2,417 | 2,391 | 2,405 | -9 | -0.4% | 155,600 |
2022/03/07 | 2,360 | 2,417 | 2,360 | 2,414 | +30 | +1.3% | 153,200 |
2022/03/04 | 2,414 | 2,414 | 2,379 | 2,384 | -30 | -1.2% | 108,800 |
2022/03/03 | 2,405 | 2,430 | 2,398 | 2,414 | +30 | +1.3% | 96,600 |
2022/03/02 | 2,394 | 2,401 | 2,379 | 2,384 | -56 | -2.3% | 113,800 |
2022/03/01 | 2,447 | 2,465 | 2,429 | 2,440 | +13 | +0.5% | 131,200 |
2022/02/28 | 2,378 | 2,428 | 2,358 | 2,427 | +58 | +2.4% | 91,300 |
2022/02/25 | 2,413 | 2,427 | 2,364 | 2,369 | -46 | -1.9% | 62,700 |
2022/02/24 | 2,369 | 2,421 | 2,361 | 2,415 | +24 | +1% | 110,400 |
2022/02/22 | 2,381 | 2,398 | 2,354 | 2,391 | -16 | -0.7% | 63,300 |
2022/02/21 | 2,394 | 2,418 | 2,383 | 2,407 | -29 | -1.2% | 65,800 |
2022/02/18 | 2,420 | 2,446 | 2,412 | 2,436 | -7 | -0.3% | 108,800 |
2022/02/17 | 2,473 | 2,473 | 2,425 | 2,443 | -33 | -1.3% | 99,800 |
751~
800
件表示中 / 3707件
類似銘柄と比較する
現在ご覧いただいている「キッセイ薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
キッセイ薬 | 389,000円 | +3.6% | +6.1% | 3.08% | 13.10倍 | 0.77倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
サワイGHD | 185,100円 | +5.9% | +24.5% | 2.97% | 12.29倍 | 1.16倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
ジーエヌアイ | 410,500円 | +21.7% | +999.9% | 0.00% | 17.20倍 | 5.69倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 376,400円 | -6.4% | -71.8% | 5.05% | 41.92倍 | 0.93倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム